Research Advances

Vitamin B2 Found to Help Cancer Cells Resist Cell Death

Researchers have discovered that vitamin B2, also known as riboflavin, helps cancer cells survive by protecting them from ferroptosis, a type of cell death caused by iron-driven oxidative damage. The study, published in Nature Cell Biology, found that vitamin B2 supports a protein called FSP1, which strengthens the antioxidant defenses of tumor cells and prevents […]

Vitamin B2 Found to Help Cancer Cells Resist Cell Death Read More »

Study Identifies Metabolic–Epigenetic Pathway Driving Ovarian Cancer Growth and Suggests New Targeted Therapy

A study published in Communications Biology has identified pyruvate carboxylase (PC) as a key driver of metabolic changes in epithelial ovarian cancer. Researchers found that high PC levels are linked to more advanced disease, metastasis, recurrence, and poorer survival. The study shows that PC helps cancer cells build up fats by boosting the production of triglycerides

Study Identifies Metabolic–Epigenetic Pathway Driving Ovarian Cancer Growth and Suggests New Targeted Therapy Read More »

CRISPR-Edited Stem Cells May Protect AML Patients From Treatment Toxicity

A new study shows that CRISPR gene editing may help protect patients with Acute Myeloid Leukemia from the harmful side effects of intensive cancer treatment. In the VBP101 trial, researchers used CRISPR-Cas9 to remove the CD33 protein from donor stem cells before transplant. This created a new blood and immune system that could resist damage

CRISPR-Edited Stem Cells May Protect AML Patients From Treatment Toxicity Read More »

New Therapy Targets “Zombie Cells” to Slow Cancer Growth and Aging

Researchers have developed a new way to eliminate harmful “zombie cells” linked to cancer and aging. These senescent cells stop dividing but remain active, releasing substances that can damage tissue and help tumors spread. Scientists discovered that the cells survive by overproducing GPX4, a protein that protects them from Ferroptosis, a form of cell death

New Therapy Targets “Zombie Cells” to Slow Cancer Growth and Aging Read More »

Study Links T-Cell Fitness to Glofitamab Success in Large B-Cell Lymphoma

A study published in Blood found that the success of the T-cell engager glofitamab in relapsed or refractory large B-cell lymphoma (LBCL) depends heavily on the health and strength of a patient’s T cells. Researchers analyzed patients from the Phase 1/2 NP30179 trial and discovered that patients who responded well to treatment maintained higher levels of

Study Links T-Cell Fitness to Glofitamab Success in Large B-Cell Lymphoma Read More »

Experimental Therapy Starves Cancer Cells by Blocking Energy Production

Researchers have developed an experimental cancer therapy called aurB that kills tumors by blocking their energy production. Inspired by bacteria living inside tumors, scientists created aurB from a bacterial protein called auracyanin. The therapy targets mitochondria, the cell’s energy source, and blocks ATP synthase, an enzyme needed to produce energy. Without energy, cancer cells struggle

Experimental Therapy Starves Cancer Cells by Blocking Energy Production Read More »

Cancer Experts Warn Biotin Supplements May Interfere With Critical Blood Tests

Doctors are warning cancer patients to be cautious about taking biotin supplements for hair and nail growth because the vitamin can interfere with important blood tests. Although biotin, also known as vitamin B7, is often promoted online as a harmless beauty supplement, experts say it can create misleading lab results that may affect cancer care.

Cancer Experts Warn Biotin Supplements May Interfere With Critical Blood Tests Read More »

New Lipid Profiling Method Shows Promise for Early Pancreatic Cancer Detection

Researchers have developed a new lipid analysis method that could improve early detection of pancreatic cancer by identifying hidden changes in blood fat molecules. The technique combines advanced mass spectrometry with specialized software to detect detailed lipid structures that standard tests often miss. The study analyzed 15 lipid classes, including ceramides and sphingomyelins, using a

New Lipid Profiling Method Shows Promise for Early Pancreatic Cancer Detection Read More »

Fra-2–Driven Resistance Limits KRAS Inhibitor Response in Pancreatic ductal adenocarcinoma, Study Finds Combination Strategy May Restore Efficacy

A study published in PNAS shows how pancreatic cancer cells develop resistance to a targeted therapy in Pancreatic ductal adenocarcinoma. Researchers focused on the KRAS inhibitor MRTX-1133, which initially blocks tumor growth by shutting down a key cancer-driving pathway. However, cancer cells quickly adapt by increasing levels of a protein called Fra-2. This triggers a

Fra-2–Driven Resistance Limits KRAS Inhibitor Response in Pancreatic ductal adenocarcinoma, Study Finds Combination Strategy May Restore Efficacy Read More »

Tumor Microenvironment Barriers Drive Treatment Resistance in Pancreatic ductal adenocarcinoma, New Research Explains Immune Failure

Pancreatic ductal adenocarcinoma remains highly resistant to treatment because of a dense and suppressive tumor environment that blocks both drugs and immune cells. Researchers describe this tumor microenvironment as “cold,” meaning it does not naturally support strong immune activity. A major component of this barrier is the tumor stroma, which is made up of several

Tumor Microenvironment Barriers Drive Treatment Resistance in Pancreatic ductal adenocarcinoma, New Research Explains Immune Failure Read More »